237 related articles for article (PubMed ID: 38791207)
1. Long Non-Coding RNAs in Sjögren's Disease.
Pastva O; Klein K
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791207
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses.
Joachims ML; Khatri B; Li C; Tessneer KL; Ice JA; Stolarczyk AM; Means N; Grundahl KM; Glenn SB; Kelly JA; Lewis DM; Radfar L; Stone DU; Guthridge JM; James JA; Scofield RH; Wiley GB; Wren JD; Gaffney PM; Montgomery CG; Sivils KL; Rasmussen A; Farris AD; Adrianto I; Lessard CJ
RMD Open; 2022 Nov; 8(2):. PubMed ID: 36456101
[TBL] [Abstract][Full Text] [Related]
3. Predicted Disease-Specific Immune Infiltration Patterns Decode the Potential Mechanisms of Long Non-Coding RNAs in Primary Sjogren's Syndrome.
Cheng C; Zhou J; Chen R; Shibata Y; Tanaka R; Wang J; Zhang J
Front Immunol; 2021; 12():624614. PubMed ID: 33936039
[TBL] [Abstract][Full Text] [Related]
4. Emerging Role of microRNAs and Long Non-Coding RNAs in Sjögren's Syndrome.
De Benedittis G; Ciccacci C; Latini A; Novelli L; Novelli G; Borgiani P
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34208031
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome.
Shi H; Cao N; Pu Y; Xie L; Zheng L; Yu C
Arthritis Res Ther; 2016 May; 18(1):109. PubMed ID: 27188286
[TBL] [Abstract][Full Text] [Related]
6. Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?
Baldini C; Berardicurti O; Giacomelli R; Bombardieri M
Autoimmun Rev; 2024 Jan; 23(1):103425. PubMed ID: 37634677
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome X-chromosome dose effect: An epigenetic perspective.
Mougeot JL; Noll BD; Bahrani Mougeot FK
Oral Dis; 2019 Mar; 25(2):372-384. PubMed ID: 29316023
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs could be potential key players in the pathophysiology of Sjögren's syndrome.
Sandhya P; Joshi K; Scaria V
Int J Rheum Dis; 2015 Nov; 18(8):898-905. PubMed ID: 26420575
[TBL] [Abstract][Full Text] [Related]
9. Association of G protein-coupled receptor 78 with salivary dysfunction in male Sjögren's patients.
Tanaka T; Guimaro MC; Nakamura H; Perez P; Ji Y; Michael DG; Afione SA; Zheng C; Goldsmith C; Swaim WD; Pedersen AML; Chiorini JA
Oral Dis; 2024 Apr; 30(3):1173-1182. PubMed ID: 36652502
[TBL] [Abstract][Full Text] [Related]
10. Emerging treatment for Sjögren's disease: a review of recent phase II and III trials.
Fox RI; Fox CM; McCoy SS
Expert Opin Emerg Drugs; 2023 Dec; 28(2):107-120. PubMed ID: 37127914
[TBL] [Abstract][Full Text] [Related]
11. X-linked genes exhibit skewed expression in Sjogren's disease (SjD): a further step toward understanding the female predominance of autoimmune disease.
Fox R
J Mol Med (Berl); 2022 Sep; 100(9):1267-1269. PubMed ID: 35982186
[No Abstract] [Full Text] [Related]
12. Text-mining applied to autoimmune disease research: the Sjögren's syndrome knowledge base.
Gorr SU; Wennblom TJ; Horvath S; Wong DT; Michie SA
BMC Musculoskelet Disord; 2012 Jul; 13():119. PubMed ID: 22759918
[TBL] [Abstract][Full Text] [Related]
13. Exploring Salivary Epithelial Dysfunction in Sjögren's Disease.
Noll B; Beckman M; Bahrani Mougeot F; Mougeot JL
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732189
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive overview of living with Sjögren's: results of a National Sjögren's Foundation survey.
McCoy SS; Woodham M; Bunya VY; Saldanha IJ; Akpek EK; Makara MA; Baer AN
Clin Rheumatol; 2022 Jul; 41(7):2071-2078. PubMed ID: 35257256
[TBL] [Abstract][Full Text] [Related]
15. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
16. Differential long non-coding RNA expression profile and function analysis in primary Sjogren's syndrome.
Chen X; Cheng Q; Du Y; Liu L; Wu H
BMC Immunol; 2021 Jul; 22(1):47. PubMed ID: 34284720
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjögren's syndrome patients with enlarged exocrine glands.
Tsubota K; Fujita H; Tadano K; Onoda N; Tsuzaka K; Takeuchi T
Clin Exp Immunol; 2002 Jul; 129(1):177-82. PubMed ID: 12100038
[TBL] [Abstract][Full Text] [Related]
18. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
19. Review of genes potentially related to hyposecretion in male non-obese diabetic (NOD) mice, a Sjögren's syndrome model.
Ohno Y; Satoh K; Kashimata M
J Oral Biosci; 2023 Sep; 65(3):211-217. PubMed ID: 37209839
[TBL] [Abstract][Full Text] [Related]
20. Proteomic diagnosis of Sjögren's syndrome.
Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
